Lisdexamfetamine Dimesylate Approved For ADHD In Adults, USA

Friday, Aug. 17th 2012 9:17 AM

In the U.S., in 2007, the prescription medication Vyvanse was introduced for the treatment of ADHD in children aged 6 to 12 years old by the US Food and Drug Administration (FDA). The following year the medication was approved to treat ADHD in adults, and approved in 2010 to treat adolescents aged 13 to 17 with ADHD.

Posted on Friday, Aug. 17th 2012 9:17 AM | by Share of Cost | in Share of Cost | Comments Off on Lisdexamfetamine Dimesylate Approved For ADHD In Adults, USA